期刊文献+

尼尔雌醇和左炔诺孕酮对人成骨肉瘤MG-63细胞株OPG/OPGL的作用

Effect of nylestriol and levonorgestrel on the expression of OPG/OPGL in human osteosarcoma MG-63 cell lines
下载PDF
导出
摘要 目的 :观察不同浓度的尼尔雌醇 (NYL)和左炔诺孕酮 (LNG)对MG 6 3细胞株OPG/OPGL表达的作用 ,探讨旁分泌效应对其表达的影响。方法 :用半定量RT PCR检测不同浓度的两种药物分别干预的MG 6 3细胞OPG/OPGLmRNA表达。结果 :两种药物均能促进MG 6 3细胞株OPG表达增多 ,最佳作用浓度均为 10 6mol/L。两者均能显著抑制OPGLmRNA表达。更换培养液可使NYL (10 10 mol/L)干预组表达OPG减少。结论 :NYL和LNG均能促进MG 6 3细胞株OPG表达 ,并抑制OPGL的表达。NYL对OPG表达调控过程中可能涉及MG 6 Objective To determine the effect of nylestriol and levonorgestrel on mRNA expression of OPG/OPGL in MG-63 cell lines,and to explore whether the paracrine effect is involved in the regulation course. Methods Semi-quantitive RT-PCR was conducted to analyze mRNA expression of OPG/OPGL in MG-63 cell lines treated with nylestriol and levonorgestrel.Results Both medicines could stimulate MG-63 cell lines to express OPG, and the best action levels of the two medicines were 10 -6 mol/L.Both medicines could decrease mRNA expression levels of OPGL dramatically. In NYL 10 -10 mol/L treatment group, medium renewal has negative effect on mRNA expression of OPG.Conclusion Both the two medicines can promote mRNA expression of OPG in MG-63 cell lines, while decrease mRNA expression of OPGL.The paracrine effect of MG-63 cell lines may be involved in the regulation of mRNA expression of OPG by NYL.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2004年第6期667-670,共4页 Journal of Central South University :Medical Science
关键词 MG-63细胞 OPG mRNA表达 左炔诺孕酮 尼尔雌醇 成骨肉瘤 旁分泌 表达调控 半定量RT-PCR 培养液 nylestriol levonorgestrel osteoprotegerin/ligand of osteoprotegerin paracrine effect
  • 相关文献

参考文献12

  • 1Riggs BL, Khosia S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes both type Ⅰ and type Ⅱ osteoporosis in postmenopausal women and contributes to bone loss in aging men[J]. J Bone Miner Res, 1998, 13(5): 763-773.
  • 2Simonet WS, Laeey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density [J]. Cell, 1997, 89(2): 309-319.
  • 3Hofbauer LC, Khosla S, Dunstan CR, et al. Estrogen stimulates gene expression and protein production of osteoprotegerin by human osbeoblastic cells [ J ]. Endocrinology, 1999, 140 ( 9 ): 4367-4370.
  • 4Lacey D, Timms E, Tan H, et al. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation [J]. Cell, 1998, 93(2): 165-176.
  • 5Franchesi RT, James WN, Zerleuth G. 1,25-dihydroxyvitamin D3 specific regulation of growth, morphology and fibronectin in a human osteosarcoma cell line [ J]. J Cell physiol, 1985, 123 (3):401-409.
  • 6罗湘杭,廖二元,周后德,邓小戈,伍贤平.雌二醇对人成骨样细胞基质金属蛋白酶及其抑制因子的作用[J].中华内科杂志,2000,39(4):243-246. 被引量:40
  • 7Fuller K, Wong B, Fox S, et al. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts[J]. J Exp Med, 1998, 188(5): 997-1001.
  • 8Burgess TL, Qian YX, Kaufman S, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts[ J]. J Cell Biol, 1999, 145(3): 527-538.
  • 9Tsuda E, Goto M, Mochizuki SI, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis [J]. Biochem Biophys Res Commun, 1997,234( 1 ) :137-142.
  • 10Dunstan CR, Capparelli C, Kelley M, et al. Osteoprotegerin (OPG), a novel TNF-receptor family member profoundly inhibits endosteal bone resorption due to growth, humoral hypercalcemia of malignancy, and interleukin-1 [J]. J Bone Miner Res, 1997, 12 (Suppl 1 ): S 136(Abstract 134).

二级参考文献9

  • 1Meikle MC,Bord S,Hembry RM,et al.Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines[].Journal of Cell Science.1992
  • 2Alvares O,Klebe R,Grant G,et al.Growth factor effects on the expression of collagenase and TIMP-1 in periodontal ligament cells[].Journal of Periodontology.1995
  • 3Carome MA,Striker LJ,Peten EP,et al.Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA[].American Journal of Physiology.1993
  • 4Rifas L,Fausto A,Scott MJ,et al.Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells:differentiation is associated with repression of metalloproteinase biosynthesis[].The Journal of Endocrinology.1994
  • 5Barzel US.Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review[].The American Journal of Medicine.1988
  • 6Takeba Y,Suzuki N,Takeno M,et al.Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis[].Arthritis and Rheumatism.1997
  • 7Vaes G.Cellular biology and biochemical mechanism of bone resorption.A review of recent developments on the formation, activation, and mode of action of osteoclasts[].Clinical Orthopaedics.1988
  • 8Holliday LS,Welgus HG,Fliszar CJ,et al.Initiation of osteoclast bone resorption by interstitial collagenase[].Journal of Biological Chemistry.1997
  • 9Murphy G.Matrix metalloproteinases and their inhibitors[].Acta Orthopaedica Scandinavica.1995

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部